![John Friend](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Friend
Algemeen Directeur bij
KAZIA THERAPEUTICS LIMITED
Vermogen: 150 $ op 31-05-2026
Profiel
John E.
Friend is Chief Executive Officer & Director at Kazia Therapeutics Ltd. since 2024.
Formerly, Senior Vice President-Medical & Scientific Affairs at Helsinn Therapeutics (U.S.), Inc. from 2010 to 2017.
Chief Medical Officer & Vice President at Cellectar Biosciences, Inc. from 2017 to 2018 and again from 2020 to 2021.
Chief Medical Officer at Druggability Technologies Holdings Ltd. (New Jersey).
Education includes undergraduate studies at Southern Methodist University and a doctorate from Robert Wood Johnson Medical School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-03-2026 | 15.000.000 ( 0,26% ) | 150 $ | 31-05-2026 |
Actieve functies van John Friend
| Bedrijven | Functie | Begin |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Algemeen Directeur | 01-05-2023 |
Eerdere bekende functies van John Friend
| Bedrijven | Functie | Einde |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 02-11-2021 |
| CELLECTAR BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 27-11-2018 |
Helsinn Therapeutics (U.S.), Inc.
 Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical products for treatment of cancer | Hoofd Techniek/Wetenschap/O&O | 01-04-2017 |
Druggability Technologies Holdings Ltd. (New Jersey) | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van John Friend
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
13
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Kazia Therapeutics Ltd.
 Kazia Therapeutics Ltd. BiotechnologyHealth Technology Engages in the business of pharmaceutical research and development | Health Technology |
Southern Methodist University
 Southern Methodist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert Wood Johnson Medical School
 Robert Wood Johnson Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical products for treatment of cancer | Health Technology |
Cellectar Biosciences, Inc.
 Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
Druggability Technologies Holdings Ltd. (New Jersey) |
Kies MarketScreener 
